- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-06-0027005

About Elisa Biotech Private Limited
Data last updated:
Elisa Biotech Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2007PTC160045. Its GSTIN is 07AABCE7564P1Z1 (Delhi).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Jyoti Nagpal and Mukesh Kumar Nagpal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 22 2nd Floor Blk – S, Badli Industrial Area Ph – 1, Delhi, India – 110042.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.59 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹35.33 Lakh (net margin 2.8%) and EBITDA of ₹53.01 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹1.14 Cr on record. Court records list 21 cases involving the company, including 12 filed by the company and 9 filed against it; 6 cases are pending.
Elisa Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0027005). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elisabiotechindia.com.
Company details
Recognitions & Rankings of Elisa Biotech
Contact details
Elisa Biotech Private Limited's registered office is in Delhi, Delhi. Its website is elisabiotechindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 22 2nd Floor Blk – S, Badli Industrial Area Ph – 1, Delhi, India – 110042
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Elisa Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elisa Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Elisa Biotech Private Limited, buy the company report.
Financials of Elisa Biotech Private Limited
FY 2025 filings availableElisa Biotech Private Limited reported revenue of ₹12.59 Cr (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 17% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹53.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elisa Biotech Private Limited, buy the company report.
Board of directors of Elisa Biotech Private Limited
Elisa Biotech has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyoti Nagpal | Director | 27 Mar 2015 | 11 Years 7 Months | Current |
| Mukesh Kumar Nagpal | Director | 02 Mar 2007 | 19 Years 7 Months | Current |
| Reena Nagpal | Director | 18 Mar 2015 | 11 Years 7 Months | Current |
Peer comparison
Elisa Biotech Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Renauxe Pharma India Private Limited | ₹12.66 Cr (FY 2023) | 23.0% | Ernakulam, Kerala, India | |||
| Vitara Cure Private Limited | ₹12.66 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Bansal Pharmachem Pvt. Ltd. | ₹12.62 Cr (FY 2024) | 4.0% | New Delhi, Delhi, India | |||
| Paradigm Medivision Private Limited | ₹12.61 Cr (FY 2019) | -21.0% | Hyderabad, Telangana, India | |||
| Elisa Biotech Private Limitedthis company | ₹12.59 Cr (FY 2025) | ₹35.33 Lakh | 2.8% | 17.0% | Delhi, India | |
| Dolvis Bio Pharma Private Limited | ₹12.57 Cr (FY 2024) | 0.0% | Manimajra, Chandigarh, India | |||
| Saamag Healthcare Professional Management Private Limited | ₹12.57 Cr (FY 2022) | -71.0% | New Delhi, Delhi, India | |||
| Health Medivision Private Limited | ₹12.56 Cr (FY 2024) | -1.0% | Delhi, India |
To see the full peer comparison of Elisa Biotech Private Limited, buy the company report.
Auditor
Elisa Biotech Private Limited is audited by RSD & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RSD & CO | FY 2023 | 01277N |
Shareholding
The shareholding of Elisa Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Elisa Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 May 2009 | 10164354 | Oriental Bank of Commerce | ₹14 Lakh | Open | |
| 13 May 2009 | 10164353 | Others | ₹1 Cr | Open |
To see the full charge records of Elisa Biotech Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Elisa Biotech Private Limited has 21 court cases on record: 12 filed by Elisa Biotech, 9 filed against it. 6 cases are pending and 15 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 20 | 8 | 6 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 21)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by M/S Wanbury Limited | Disposed |
| District court, Central, Delhi | Civil suit | Filed against the company by State | Pending |
| District court, North, Delhi | Cheque dishonour complaint | Filed by the company against M/S Malik Medicine Agency Through Its Proprietor Mohd. Abbas | Pending |
| District court, North, Delhi | Cheque dishonour complaint | Filed by the company against Mohammed Munawar, Proprietor of M/S M F Pharma Distributors | Pending |
| District court, North, Delhi | Criminal case | Filed by the company against individuals | Pending |
To see the full case history of Elisa Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elisa Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elisa Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCE7564P1Z1 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Elisa Biotech Private Limited, buy the company report.
Recent activity
Elisa Biotech Private Limited has 7 board changes on record since 2007: 3 appointments and 4 cessations. The latest: Rajender Kumar ceased to be Director on 05 Mar 2018.
1 earlier event is in the company report.
Frequently asked questions
Elisa Biotech is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 March 2007 (19+ years old) and is registered under CIN U24232DL2007PTC160045.
Elisa Biotech has 3 current directors:
- Jyoti Nagpal - Director
- Mukesh Kumar Nagpal - Director
- Reena Nagpal - Director
The latest financial statements of Elisa Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Elisa Biotech is 07AABCE7564P1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Elisa Biotech is U24232DL2007PTC160045. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elisa Biotech has 21 court cases on record: 12 filed by the company and 9 filed against it. 6 are pending. Most are in the district courts.
Elisa Biotech was incorporated on 02 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Elisa Biotech by revenue are Renauxe Pharma India Private Limited, Vitara Cure Private Limited, Bansal Pharmachem Pvt. Ltd, Paradigm Medivision Private Limited, Dolvis Bio Pharma Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Rajender Kumar ceased to be Director on 05 Mar 2018. Jyoti Nagpal ceased to be Additional Director on 30 Sep 2015. Reena Nagpal ceased to be Additional Director on 30 Sep 2015. Elisa Biotech has 7 board changes on record in total.
Yes, Elisa Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-DL-06-0027005).
Elisa Biotech can be reached through the website elisabiotechindia.com. Its registered office is in Delhi, India.

